All Cases

Patient Journey Mapping

Identified emotional drivers influencing treatment selection at specific points in the patient journey for a rare disease

Mapped key decisions and drivers of adoption for a blockbuster hematology product, informing strategic planning at a large pharmaceutical company looking to expand to new indications

Developed drivers and potential barriers of Hematologist GTx adoption to understand the impacts on patient adoption and inform strategic commercialization planning for a mid-sized biotech

Investigated adoption pain points for an appetite suppressant and their impact on adoption / adherence to underpin financial modeling and inform strategic commercialization investment at a small biotech

Characterized potential adoption challenges for a developmental allergic conjunctivitis product to facilitate strategic commercialization planning at a mid-sized ophthalmology company

Identified Drivers of Physician Switch in dry eye disease, informing the commercial strategy of a mid-sized, ophthalmology company